Medicinal product name Febuxostat Krka
Pharmaceutical form Film-coated tablet
Strength 120 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code M04AA03 Antigout preparations

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N56
(120 mg)
PVC/PVDC/PVC-Al blister    EU/1/18/1347/007  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/18/1347/007
Date of authorisation Mar 28, 2019
Marketing authorisation holder, country KRKA, d.d., Novo mesto, Slovenia